首页> 外文期刊>The journal of clinical psychiatry >Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants: A Randomized, Double-Blind, Placebo-Controlled Study in Adult Patients With Major Depressive Disorder
【24h】

Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants: A Randomized, Double-Blind, Placebo-Controlled Study in Adult Patients With Major Depressive Disorder

机译:抗抑郁药物反应不良的辅助卡比拉嗪的疗效和安全性:成年抑郁症成年患者的一项随机,双盲,安慰剂对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Cariprazine is an atypical antipsychotic currently under investigation as adjunctive therapy in patients with major depressive disorder (MDD) who have inadequate response to standard antidepressant therapy.
机译:背景:卡立哌嗪是一种非典型抗精神病药物,目前正在研究中,作为对标准抗抑郁疗法反应不足的重度抑郁症(MDD)患者的辅助疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号